Eli Lilly and Company (LLY)
NYSE: LLY · IEX Real-Time Price · USD
745.69
+14.36 (1.96%)
At close: Apr 23, 2024, 4:00 PM
748.66
+2.97 (0.40%)
Pre-market: Apr 24, 2024, 7:51 AM EDT
Eli Lilly Market Cap
Eli Lilly has a market cap or net worth of $708.98 billion as of April 24, 2024. Its market cap has increased by 100.36% in one year.
Market Cap
708.98B
Enterprise Value
731.27B
1-Year Change
100.36%
Ranking
Category
Stock Price
$745.69
Market Cap Chart
Since December 1, 1998, Eli Lilly's market cap has increased from $99.25B to $708.98B, an increase of 614.35%. That is a compound annual growth rate of 8.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2024 | 708.53B | 1.96% |
| Apr 22, 2024 | 694.88B | 0.69% |
| Apr 19, 2024 | 690.11B | -2.63% |
| Apr 18, 2024 | 708.78B | -0.64% |
| Apr 17, 2024 | 713.36B | 0.54% |
| Apr 16, 2024 | 709.53B | -0.54% |
| Apr 15, 2024 | 713.36B | -0.12% |
| Apr 12, 2024 | 714.18B | -1.05% |
| Apr 11, 2024 | 721.74B | -0.31% |
| Apr 10, 2024 | 724.01B | 0.63% |
| Apr 9, 2024 | 719.50B | -2.58% |
| Apr 8, 2024 | 738.55B | -0.88% |
| Apr 5, 2024 | 745.13B | 2.10% |
| Apr 4, 2024 | 729.80B | -1.02% |
| Apr 3, 2024 | 737.32B | 1.57% |
| Apr 2, 2024 | 725.89B | 0.45% |
| Apr 1, 2024 | 722.65B | -2.24% |
| Mar 28, 2024 | 739.19B | -0.03% |
| Mar 27, 2024 | 739.40B | 0.42% |
| Mar 26, 2024 | 736.28B | 0.23% |
| Mar 25, 2024 | 734.61B | 0.33% |
| Mar 22, 2024 | 732.21B | 0.05% |
| Mar 21, 2024 | 731.87B | -0.34% |
| Mar 20, 2024 | 734.34B | 0.01% |
| Mar 19, 2024 | 734.27B | 1.33% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 563.41B |
| UnitedHealth Group | 453.00B |
| Johnson & Johnson | 359.52B |
| Merck & Co. | 322.84B |
| AbbVie | 300.85B |
| AstraZeneca | 218.51B |
| Thermo Fisher | 218.44B |
| Novartis AG | 192.46B |